Zurex Pharma develops a portfolio of antimicrobial products designed to prevent healthcare acquired infections.
Zurex Pharma has raised $3.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2023.
Zurex Pharma's investors include Baird Capital, State of Wisconsin Investment Board, Wisconsin Investment Partners, Square 1 Bank, Peak Ridge Capital.
Zurex Pharma is headquartered in Middleton, United States.
Zurex Pharma develops a portfolio of antimicrobial products designed to prevent healthcare acquired infections.
Zurex Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zurex Pharma — Funding & Investors." VCBacked, December 28, 2023, https://www.vcbacked.co/company/zurex-pharma. Accessed September 29, 2026.
VCBacked. (2023). Zurex Pharma — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/zurex-pharma
{{cite web |title=Zurex Pharma — Funding & Investors |url=https://www.vcbacked.co/company/zurex-pharma |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated